Nazarbayev University and BGI Genomics Sign MoU for Better Health Outcomes in Kazakhstan
Prof. Massimo Pignatelli, Vice-President for Medicine and Dean of the School of Medicine, Nazarbayev University., Dr. Ning Li, Deputy General Manager, BGI Genomics & Jun Cheng, General Director of CIS region, BGI Genomics. Source: NU.
Nazarbayev University (NU) and BGI Genomics signed a Memorandum of Understanding (MoU) to establish and develop cooperation in personalized medicine and genetic technologies at Nazarbayev University School of Medicine.
The MOU was signed by Dr. Ning Li, Deputy General Manager, BGI Genomics and Prof. Massimo Pignatelli, Vice-President for Medicine and Dean of the School of Medicine, Nazarbayev University.
NU and BGI Genomics are committed to working together on clinical and research development, educational initiatives, and integrated solutions for assessing human health.
This partnership aims to explore the application of genomics, proteomics, metabolomics, transcriptomics and novel technologies to develop innovative diagnostic, therapeutic measures and disease prevention.
NU and BGI Genomics agreed to organize joint scientific and educational conferences and seminars on cutting-edge technology in biomedicine to support and complement the research and development capability and infrastructure of NU Medicine.
First Published: Nazarbayev University
NIFTY® DNBSEQ-G99 Platform Achieves CE-IVDD Certification - Enhancing Prenatal Care Options
World Cancer Day 2024: Close the Care Gap through Awareness, Early Detection, and Universal Access l BGI Perspectives